Drug Shortage Report for SANDOZ MOMETASONE

Last updated on 2022-01-18 History
Report ID 148761
Drug Identification Number 02449811
Brand name SANDOZ MOMETASONE
Common or Proper name MOMETASONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 50MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL NASAL
Packaging size 140DOS LSP
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-03
Estimated end date 2022-01-28
Actual end date 2022-01-17
Shortage status Resolved
Updated date 2022-01-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-11-03 English Compare
v2 2021-11-03 French Compare
v3 2021-11-24 English Compare
v4 2021-11-24 French Compare
v5 2021-12-06 English Compare
v6 2021-12-06 French Compare
v7 2021-12-20 English Compare
v8 2021-12-20 French Compare
v9 2022-01-12 English Compare
v10 2022-01-12 French Compare
v11 2022-01-18 English Compare
v12 2022-01-18 French Compare

Showing 1 to 12 of 12